Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilya Ayzenberg

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Der Nervenarzt|March 30, 2021
[Treatment of antibody-mediated encephalomyelitis : Strategies for the treatment of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease]Ilya Ayzenberg, Ingo Kleiter
Therapeutics and Clinical Risk Management|March 2, 2016
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerationsIlya Ayzenberg, Robert Hoepner, Ingo Kleiter
Clinical Neuroradiology|August 16, 2017
Twig-like Middle Cerebral Artery: a Seldom Vessel Anomaly of Important RelevanceTheodor Lutz, Peter Mönnings, Ilya Ayzenberg, et al.
Annals of Neurology|June 5, 2020
Reader Response: Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody DiseasesCarolin Schwake, Kerstin Hellwig, Ralf Gold, et al.
Journal of Neurology|August 4, 2016
Charles Bonnet syndrome successfully treated with levetiracetamThomas Grüter, Ilya Ayzenberg, Ralf Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2016
Tocilizumab, MS, and NMOSDIngo Kleiter, Ilya Ayzenberg, Manabu Araki, et al.
Journal of Neurology|May 24, 2020
Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 diseaseThomas Grüter, Volker Behrendt, Corinna I Bien, et al.
Neurological Research and Practice|December 16, 2020
General principles and escalation options of immunotherapy in autoantibody-associated disorders of the CNSIlya Ayzenberg, Simon Faissner, Laura Tomaske, et al.
Multiple Sclerosis and Related Disorders|July 30, 2018
Flaccid paralysis in neuromyelitis optica: An atypical presentation with possible involvement of the peripheral nervous systemThomas Grüter, Ilya Ayzenberg, Anna Gahlen, et al.
Neurological Research and Practice|June 19, 2026
Unmet needs in the care of patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody associated disease: insights from GermanyKatrin Giglhuber, Alix Bertrand, Clarissa Zappe, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Der Nervenarzt|March 30, 2021
[Treatment of antibody-mediated encephalomyelitis : Strategies for the treatment of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease]Ilya Ayzenberg, Ingo Kleiter
Therapeutics and Clinical Risk Management|March 2, 2016
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerationsIlya Ayzenberg, Robert Hoepner, Ingo Kleiter
Clinical Neuroradiology|August 16, 2017
Twig-like Middle Cerebral Artery: a Seldom Vessel Anomaly of Important RelevanceTheodor Lutz, Peter Mönnings, Ilya Ayzenberg, et al.
Annals of Neurology|June 5, 2020
Reader Response: Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody DiseasesCarolin Schwake, Kerstin Hellwig, Ralf Gold, et al.
Journal of Neurology|August 4, 2016
Charles Bonnet syndrome successfully treated with levetiracetamThomas Grüter, Ilya Ayzenberg, Ralf Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2016
Tocilizumab, MS, and NMOSDIngo Kleiter, Ilya Ayzenberg, Manabu Araki, et al.
Journal of Neurology|May 24, 2020
Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 diseaseThomas Grüter, Volker Behrendt, Corinna I Bien, et al.
Neurological Research and Practice|December 16, 2020
General principles and escalation options of immunotherapy in autoantibody-associated disorders of the CNSIlya Ayzenberg, Simon Faissner, Laura Tomaske, et al.
Multiple Sclerosis and Related Disorders|July 30, 2018
Flaccid paralysis in neuromyelitis optica: An atypical presentation with possible involvement of the peripheral nervous systemThomas Grüter, Ilya Ayzenberg, Anna Gahlen, et al.
Neurological Research and Practice|June 19, 2026
Unmet needs in the care of patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody associated disease: insights from GermanyKatrin Giglhuber, Alix Bertrand, Clarissa Zappe, et al.
Pageof 11